- Home
- OBIO vs NEWT Comparison
OBIO vs NEWT Comparison
Compare OBIO & NEWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- NEWT
- Stock Information
- Founded
- OBIO 2017
- NEWT 1998
- Country
- OBIO United States
- NEWT United States
- Employees
- OBIO N/A
- NEWT N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- NEWT Major Banks
- Sector
- OBIO Health Care
- NEWT Finance
- Exchange
- OBIO Nasdaq
- NEWT Nasdaq
- Market Cap
- OBIO 172.1M
- NEWT 316.7M
- IPO Year
- OBIO N/A
- NEWT N/A
- Fundamental
- Price
- OBIO $3.32
- NEWT $10.48
- Analyst Decision
- OBIO Strong Buy
- NEWT Hold
- Analyst Count
- OBIO 4
- NEWT 4
- Target Price
- OBIO $14.00
- NEWT $13.25
- AVG Volume (30 Days)
- OBIO 341.9K
- NEWT 215.1K
- Earning Date
- OBIO 11-11-2025
- NEWT 10-29-2025
- Dividend Yield
- OBIO N/A
- NEWT 7.25%
- EPS Growth
- OBIO N/A
- NEWT 21.23
- EPS
- OBIO N/A
- NEWT 2.01
- Revenue
- OBIO $2,944,000.00
- NEWT $364,004,000.00
- Revenue This Year
- OBIO $29.26
- NEWT N/A
- Revenue Next Year
- OBIO $10.65
- NEWT $12.40
- P/E Ratio
- OBIO N/A
- NEWT $5.21
- Revenue Growth
- OBIO 41.61
- NEWT 20.91
- 52 Week Low
- OBIO $2.20
- NEWT $9.12
- 52 Week High
- OBIO $6.50
- NEWT $15.49
- Technical
- Relative Strength Index (RSI)
- OBIO 63.60
- NEWT 29.08
- Support Level
- OBIO $2.66
- NEWT $10.59
- Resistance Level
- OBIO $3.80
- NEWT $11.11
- Average True Range (ATR)
- OBIO 0.26
- NEWT 0.34
- MACD
- OBIO 0.10
- NEWT -0.09
- Stochastic Oscillator
- OBIO 67.14
- NEWT 9.12
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About NEWT NewtekOne Inc.
NewtekOne Inc is a financial holding company engaged in providing financial solutions to its Client Base. It is an internally managed non-diversified closed-end management investment company. It has four reportable segments Banking, Alternative Lending, Technology, NSBF, and Payments.